PremiumCompany AnnouncementsDay One Biopharma’s Earnings Call Highlights Growth Day One price target lowered to $26 from $30 at JonesResearch Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position PremiumRatingsPositive Growth Outlook for Day One Biopharmaceuticals Driven by Strong Q1 Performance and Strategic Initiatives Day One Biopharmaceuticals Reports Q1 2025 Financial Results Day One Biopharmaceuticals reports Q1 EPS (35c), consensus (44c) PremiumThe FlyDay One Biopharmaceuticals price target lowered to $34 from $39 at JPMorgan Day One Biopharma’s Earnings Call Highlights Growth and Challenges Day One price target lowered to $30 from $34 at JonesResearch 
